EnGene Holdings Inc. experienced a 38.7% rise in short interest in September, reaching 216,700 shares.
enGene Holdings Inc. reported a 38.7% rise in short interest in September, totaling 216,700 shares. The stock price increased to $6.05, with 1.3% sold short and a days-to-cover ratio of 1.8. The company posted a Q3 earnings per share of ($0.32), slightly better than estimates. Analysts maintain a "Buy" rating with a 12-month target of $33.67, while institutional investors hold over 64% of the stock. The market cap is $267.20 million.
September 29, 2024
4 Articles